Search by Journal
- HOME
- > Search by Journal
- > Japanese Journal of Transplantation and Cellular Therapy
Japanese Journal of Transplantation and Cellular Therapy
Volume 11, Issue 1 / 2022
English Article 
Japanese Article- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
|
Current global trends in the development of CAR-T therapy Hiroshi Fujiwara Japanese Journal of Transplantation and Cellular Therapy 11(1): 1-9, 2022. |
|---|
|
|
Effect of antithymocyte globulin on chronic GVHD and prognosis of allogeneic hematopoietic stem cell transplantation Souichi Shiratori Japanese Journal of Transplantation and Cellular Therapy 11(1): 10-21, 2022. |
|---|
|
|
What are the risks and benefit of a transplant for elderly patients? Sumiko Kobayashi Japanese Journal of Transplantation and Cellular Therapy 11(1): 22-35, 2022. |
|---|
|
|
Pre-transplant conditioning regimens in allogeneic transplantation for patients with aplastic anemia Shinichi Kako Japanese Journal of Transplantation and Cellular Therapy 11(1): 36-42, 2022. |
|---|
|
|
Hematopoietic cell transplantation for myelodysplastic syndromes Masayuki Shiseki Japanese Journal of Transplantation and Cellular Therapy 11(1): 43-52, 2022. |
|---|
|
|
Post-transplant GVHD in the era of molecularly targeted therapy Yasuo Mori Japanese Journal of Transplantation and Cellular Therapy 11(1): 53-63, 2022. |
|---|
|
Short-term methotrexate plus cyclosporine for graft-versus-host disease prophylaxis after single-unit cord blood transplantation following reduced-intensity conditioning Takeshi Sugio1,2, Koji Kato1, Shuro Yoshida2, Noriyuki Saito2, Ichiro Kawano2, Hideho Henzan2, Toshihiro Miyamoto1, Koichi Akashi1, Tetsuya Eto2 Japanese Journal of Transplantation and Cellular Therapy 11(1): 64-71, 2022. |
|---|
|
|
Survey on delirium in allogeneic hematopoietic cell transplant patients at our hospital Yasuka Sawada1, Chiko Kobayashi1, Tomomi Chiba2, Yuki Wakiguchi3 Japanese Journal of Transplantation and Cellular Therapy 11(1): 72-80, 2022. |
|---|
